The independent source for health policy research, polling, and news.
1,281-1,300 of 3,363 results
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
With the future of Obamacare on the line, workers might want to consider what benefits they have gained through the landmark law.
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Follow the twists and turns of the orphan drug industry over the past three decades.
The FDA and other agencies are loosening restrictions on hearing aid sales and opening the door to less expensive, over-the-counter products.
More work is needed to improve health care in U.S., but there are no “silver bullets” to get the job done, Health and Human Services Secretary Sylvia Burwell tells the National Press Club in a farewell speech defending Obamacare.
Mammograms find many slow-growing cancers that aren’t life-threatening and shouldn’t be treated, a Danish study said.
Medi-Cal’s controversial program to go after your assets when you die will be significantly curtailed, but some enrollees could be hit by new claims.
Premiums on 2017 plans are rising by comparable amounts both in counties where multiple insurers still compete and in those where only one insurer remains after several companies stopped selling individual plans under the health law, according to Avalere, a consulting firm.
The incoming HHS secretary wants to boldly reform the malpractice system, saying hundreds of billions are wasted on “lawsuit abuse” and defensive medicine. Industry experts say premiums and claims are down and “it’s a wonderful time for doctors.”
A study found that Medicare’s bundled payments model for joint replacement could save the government billions of dollars without harming patient care.
The federal government pays for kidney transplants. But the program only pays for essential anti-rejection drugs for three years. Many people can't afford them and can end up losing the kidney.
Pilot projects are being launched in 18 counties to reduce ER visits among Medi-Cal's most costly patients.
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.
Medicare is launching new regulations in January that will provide higher reimbursements for doctors involved in care coordination for seriously ill people.
Eight percent of those polled by the Kaiser Family Foundation say they have purchased medications outside of the U.S. to save money.
Infertility treatment rarely is covered by health insurance. And more couples who need it to conceive are turning to crowdfunding sites.
Patients sometimes find an additional charge, generally between $30 and $200, tacked onto their bill for visiting a hospital emergency room between 10 p.m. and 8 a.m.
Thousands of people mistakenly think that if they have insurance, they can wait to sign up for Medicare Part B. Generally, insurance other than that provided by a current employer will not exempt them from Medicare’s strict enrollment requirements.
A breakdown of winners — and a few losers — in the sprawling Cures Act approved by the House.
© 2026 KFF